S. 3990119th CongressIn committeeLatest action Mar 4, 2026Decoded by AI · checked against the record
Official title: PrEP Access and Coverage Act of 2026
Introduced:
Read the official bill on Congress.govThe plain-language version leads. The official text is always the reference.
Most U.S. health plans would be required to cover HIV prevention drugs and related care with no out-of-pocket costs to patients.
70-second read · 5 questions answered below
This bill would require nearly all U.S. health insurance programs to cover FDA-approved HIV prevention medications, known as PrEP and PEP, along with related lab tests, doctor visits, and follow-up care at no cost to the patient. Plans generally could not require prior approval before covering these services, though they may require prior approval for a specific brand-name drug as long as a no-prior-approval alternative is available. The bill also makes it illegal for life, disability, or long-term care insurers to deny coverage or charge higher premiums to someone simply because they take HIV prevention medication.
This bill affects people enrolled in private insurance, Medicare, Medicaid, CHIP, the Federal Employees Health Benefits Program, VA health care, and TRICARE. People who are uninsured or underinsured may also be reached through grants awarded to states, tribes, and nonprofit organizations.
If insurers or other covered entities violate the bill's requirements, people who are harmed could sue in federal court and, if they win, have their legal costs covered by the defendant. Without this bill, current coverage of HIV prevention medications and related care would remain inconsistent across insurance programs.
AI-drafted summary. Verify it against the official text before you act on it. Read the official bill on Congress.gov
Right now: a Senate committee is reviewing it. If the House changes it, it goes back to the Senate before reaching the President.
Latest action: — Read twice and referred to the Committee on Health, Education, Labor, and Pensions.